Credo Health secures $5.25M in seed funding

Investment Round and Leading Participants

In the latest funding round, FCA Venture Partners took the lead, supported by existing investors such as Hannah Grey VC, FirstMile Ventures, and Springtime Ventures.

This financial backing signifies a strong vote of confidence in the company’s potential and strategic direction.

Utilization of Funds for Growth and Innovation

The injected capital is earmarked for several key initiatives that align with the company’s growth strategy.

Credo Health plans to reinforce its technological infrastructure, a crucial step in ensuring the scalability and efficiency of its operations.

Additionally, a portion of the funds will be allocated to expanding the sales team, emphasizing the importance of market outreach and customer acquisition.

Notably, the company aims to foster innovation within the value-based care market, signaling a commitment to staying at the forefront of advancements in healthcare services.

Credo Health’s Unique Offering and Leadership

Carm Huntress, the Founder and CEO of Credo Health, spearheads the company’s mission.

Under his leadership, Credo Health has developed a distinctive product known as PreDx.

This offering provides a comprehensive pre-encounter risk analysis, clinical summaries, and HEDIS Gap Closure through the application of artificial intelligence to analyze digital medical records.

The objective is to empower healthcare providers with insightful data, enabling them to make more informed clinical decisions and deliver personalized care.

Holistic Approach to Patient Information

Credo Health’s approach involves a seamless integration of digital and manual medical record retrieval.

The synergy of AI-driven analysis and human expertise ensures that healthcare providers obtain a complete clinical picture of each patient.

By combining technology and human insight, Credo Health seeks to elevate the quality of patient care and contribute to advancements in the healthcare industry.


As Credo Health secures this latest round of funding, it not only validates its current standing in the market but also positions the company for continued growth and innovation.

The strategic use of funds, emphasis on technological enhancements, and the unique PreDx product underline Credo Health’s commitment to shaping the future of value-based care.

Advertisement: Download Vital Signs App (VS App)